UNSPSC 51332203: Timelotem

This classification denotes an antipsychotic agent with the molecular formula C17H18FN3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 090DE9CRP1, chemically known as 1,2,3,4,4a,5-hexahydro-10-fluoro-3-methyl-7-(2-thienyl)pyrazino(1,2-a)(1,4)benzodiazepine but generally known as timelotem, which bears US NIH Compound Identifier 65844. European Medicines Agency schedules Timelotem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11063MIG.

UNSPSC 51332203 Timelotem, a Commodity code, spans the procurement of pharmaceutical products and drug-management systems by state and local health and human services agencies. State and local governments buy naloxone and drug deactivation systems, generic pharmaceuticals with specific National Drug Codes, and over-the-counter products through this code, often in support of community health initiatives, pharmacy benefit programs, and multi-jurisdictional cooperative purchasing arrangements. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across member jurisdictions. The work involves managing product specifications by NDC code, coordinating quarterly or ongoing deliveries to health facilities, and ensuring compliance with manufacturing standards such as current Good Manufacturing Practices and the Drug Supply Chain Security Act.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida released an IFB (No. IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with bids due July 26, 2023. The Texas Health and Human Services Commission issued RFI No. HHS0017013 on April 3, 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP (No. S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and awards effective July 1, 2026. Vendors must work through authorized wholesalers, maintain NDC-level product specifications, and comply with comprehensive insurance and regulatory requirements including FDA compliance and chargeback systems with authorized distributors.